Description
The global automated suturing devices market was valued at USD 628.4 million in 2025 and is projected to reach USD 989.4 million by 2032, registering a CAGR of 6.7% during the forecast period. Automated suturing devices are advanced surgical instruments designed to automate tissue closure with greater precision, consistency, and efficiency compared to conventional manual suturing techniques. These devices are increasingly utilized across minimally invasive, laparoscopic, robotic-assisted, and open surgical procedures to reduce operative time, improve wound closure quality, and enhance patient outcomes. The growing number of surgical procedures, increasing incidence of trauma and chronic diseases, and rapid adoption of minimally invasive surgical techniques are among the major factors driving market growth.
Market expansion is further supported by technological advancements in robotic-assisted surgery, increasing healthcare investments, and growing demand for outpatient surgical procedures. Hospitals and ambulatory surgical centers are increasingly adopting automated suturing technologies to improve operating room efficiency, minimize surgeon fatigue, and standardize wound closure across complex procedures. Continuous innovation in disposable and reusable suturing devices, integration with robotic surgical platforms, and improvements in ergonomic device design continue to strengthen market adoption. North America currently dominates the global market owing to advanced surgical infrastructure and high adoption of innovative medical technologies, while Asia Pacific is expected to witness the fastest growth due to expanding healthcare infrastructure, rising surgical volumes, and increasing investments in advanced surgical devices.
Key Highlights of the Report
• By product type, disposable automated suturing devices dominate the global automated suturing devices market, owing to their convenience, reduced risk of cross-contamination, and widespread adoption across high-volume surgical procedures.
• Reusable automated suturing devices are expected to witness steady growth, supported by cost-effectiveness over repeated use and increasing adoption in large healthcare institutions.
• By application, gastrointestinal surgery accounts for the largest market share, driven by the growing number of laparoscopic and minimally invasive gastrointestinal procedures worldwide.
• Cardiovascular surgery is projected to register significant growth, fueled by the increasing prevalence of cardiovascular diseases and growing adoption of precision surgical technologies.
• Gynecological surgery continues to represent a major application segment, supported by increasing minimally invasive hysterectomy and pelvic reconstructive procedures.
• Orthopedic surgery is witnessing rising adoption, owing to increasing trauma cases, sports injuries, and joint reconstruction procedures requiring efficient wound closure.
• Ophthalmic surgery remains an important market segment, reflecting growing utilization of precision suturing technologies in delicate microsurgical procedures.
• By end use, hospitals dominate the global automated suturing devices market, supported by high surgical procedure volumes, availability of advanced operating room infrastructure, and increasing investments in robotic-assisted surgery.
• Ambulatory surgical centers are expected to witness the fastest growth, driven by the increasing shift toward outpatient surgical procedures, shorter hospital stays, and demand for efficient surgical workflows.
• Specialty clinics continue to expand adoption, particularly for minimally invasive procedures requiring advanced wound closure technologies.
• The growing number of surgical procedures remains one of the primary market drivers, increasing demand for automated suturing solutions that improve procedural efficiency and clinical outcomes.
• Rapid advancements in robotic-assisted surgery are accelerating market growth, enabling enhanced surgical precision, reduced variability in suturing quality, and improved patient recovery.
• Increasing adoption of minimally invasive surgical techniques continues to create significant market opportunities, encouraging healthcare providers to invest in advanced automated suturing technologies.
• North America dominates the global automated suturing devices market, supported by advanced healthcare infrastructure, strong reimbursement systems, high surgical procedure volumes, and early adoption of innovative surgical technologies.
• Asia Pacific is anticipated to witness the fastest growth, driven by expanding healthcare infrastructure, increasing surgical demand, rising healthcare expenditure, and growing adoption of minimally invasive surgery.
• The competitive landscape is moderately consolidated, with leading companies focusing on robotic-assisted surgical integration, disposable device innovation, product launches, strategic collaborations, and research and development to strengthen their market position.
Key Company Profiles
• Anchora Medical
• Boston Scientific
• ErgoSuture
• Johnson & Johnson MedTech
• LSI Solutions
• Medtronic
• Mellon Medical
• Suturion
Data Source
Apelo Consulting employs comprehensive primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by Apelo Consulting dedicated team of qualified professionals with deep industry experience and expertise.
